8VC
Venture CapitalAustin, USASee on the map8vc.com
8VC is a technology investment firm that builds and invests in companies across areas including life sciences, healthcare, manufacturing, enterprise, logistics and defense.
- 4
- Portfolio companies on reccy
- 1
- Hiring now
- 5
- Open roles in the portfolio
- Oct 2026
- Latest portfolio round
Hiring now in the portfolio5
Apply on each company's site- Added to reccy 1d ago
Surgical Development and Human Factors Lead
Coherence · San Francisco
- Added to reccy 1d ago
Senior Design Assurance Engineer
Coherence · San Francisco or Cambridge, UK
- Added to reccy 1d ago
Principal Electrical Engineer, Implant Electronics
Coherence · San Francisco
- Added to reccy 1d ago
Electrical Engineer, Implant Electronics
Coherence · San Francisco
- Added to reccy 1d ago
Global Operations Lead
Coherence · San Francisco
Portfolio on reccy4
From company funding records- Series A · $45M · Oct 20265 roles
Coherence
Cambridge, UK · Led a round · Series A · $45M · Oct 2026
- Series B · $112M · Jul 2021None
Shape Therapeutics
Seattle, Washington, United States · Led a round · Series B · $112M · Jul 2021
- Not recordedNone
Amae Health
San Francisco, CA
- SeedNone
Amber Therapeutics
London, UK · Led a round · Seed
Their companies, round by round
From company funding records- CoherenceCambridge, UK
Brain-computer interfaces · Neuromodulation
- Oct 2026Series A · $45MLed
- Nov 2025Seed · $10M
- Apr 2023Seed · $5.1M
- Mar 2023Pre Seed · $2.3M
- Aug 2022Grant
- Shape TherapeuticsSeattle, Washington, United States
- Jul 2026Grant
- Jul 2021Series B · $112MLed
- Nov 2019Series A · $35.5M
- Jan 2019Spinoff / Spinout
- Amae HealthSan Francisco, CA
- Nov 2025Series B · $25M
- UndatedSeries A · $15M
- UndatedSeed
- Amber TherapeuticsLondon, UK
Neuromodulation
- Mar 2026Non-equity assistance
- UndatedSeries A
- UndatedSeedLed
- UndatedGrant
Rounds marked Led list 8VC as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Oct 2026
Coherence · Series A $45MLead
With OpenAI, Founders Fund, OpenAI Startup Fund, Lux Capital, Timeless, Olive Capital, Ahren
- Jul 2021
Shape Therapeutics · Series B $112MLead
With Decheng Capital, Breton Capital Management, New Enterprise Associates, Cherubic Ventures, Mission BioCapital, CureDuchenne Ventures, Highbury Group, Sofinnova Investments, VZVC, Willett Advisors, Menlo Ventures, Breton Capital Ventures
- Undated
Amber Therapeutics · SeedLead
Portfolio in the news
From the Cortex · last 12 months- Oct 2026